Toshikatsu Hanada

Prof. Dr. Toshikatsu Hanada

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Cells
Verified
Journal Article
Open access
PDF file
NSNobuyuki Shimizu
Nobuyuki Shimizu
HSHiroshi Shiraishi
Hiroshi Shiraishi
THToshikatsu Hanada
Toshikatsu Hanada
Liver diseases represent a significant global health challenge, thereby necessitating extensive research to understand their intricate complexities and to develop effective treatments. In this context, zebrafish (Danio rerio) have emerged as a valuable model organism for studying various aspects of liver disease. The zebrafish liver has striking similarities to the human liver in terms of structure, function, and regenerative capacity. Researchers have successfully induced liver damage in zebrafish using chemical toxins, genetic manipulation, and other methods, thereby allowing the study of disease mechanisms and the progression of liver disease. Zebrafish embryos or larvae, with their transparency and rapid development, provide a unique opportunity for high-throughput drug screening and the identification of potential therapeutics. This review highlights how research on zebrafish has provided valuable insights into the pathological mechanisms of human liver disease.

1 May 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MIMasanori Inoue
Masanori Inoue
KHKazumasa Hada
Kazumasa Hada
HSHiroshi Shiraishi
Hiroshi Shiraishi
HYHiroyuki Yatsuka
Hiroyuki Yatsuka
HFHiroyuki Fujinami
Hiroyuki Fujinami
THToshikatsu Hanada
Toshikatsu Hanada

31 July 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
HSHiroshi Shiraishi
Hiroshi Shiraishi
NSNobuyuki Shimizu
Nobuyuki Shimizu
RURyohei Umeda
Ryohei Umeda
SLShaohong Lai
Shaohong Lai
THToshikatsu Hanada
Toshikatsu Hanada

28 May 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
SLShaohong Lai
Shaohong Lai
HSHiroshi Shiraishi
Hiroshi Shiraishi
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
NSNobuyuki Shimizu
Nobuyuki Shimizu
RURyohei Umeda
Ryohei Umeda
THToshikatsu Hanada
Toshikatsu Hanada
SMG9 is an essential component of the nonsense-mediated mRNA decay (NMD) machinery, a quality control mechanism that selectively degrades aberrant transcripts. Mutations in SMG9 are associated with heart and brain malformation syndrome (HBMS). However, the molecular mechanism underlying HBMS remains unclear. We generated smg9 mutant zebrafish (smg9oi7/oi7) that have a lifespan of approximately 6 months or longer, allowing for analysis of the in vivo function of Smg9 in adults in more detail. smg9oi7/oi7 zebrafish display congenital brain abnormalities and reduced cardiac contraction. Additionally, smg9oi7/oi7 zebrafish exhibit a premature aging phenotype. Analysis of NMD target mRNAs shows a trend toward increased mRNA levels in smg9oi7/oi7 zebrafish. Spermidine oxidase (Smox) is increased in smg9oi7/oi7 zebrafish, resulting in the accumulation of byproducts, reactive oxygen species, and acrolein. The accumulation of smox mRNA due to NMD dysregulation caused by Smg9 deficiency leads to increased oxidative stress, resulting in premature aging.

16 April 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MIMasanori Inoue
Masanori Inoue
HMHiroaki Miyahara
Hiroaki Miyahara
HSHiroshi Shiraishi
Hiroshi Shiraishi
NSNobuyuki Shimizu
Nobuyuki Shimizu
MTMika Tsumori
Mika Tsumori
THToshikatsu Hanada
Toshikatsu Hanada
Leucyl-tRNA synthetase (LARS) is an enzyme that catalyses the ligation of leucine with leucine tRNA. LARS is also essential to sensitize the intracellular leucine concentration to the mammalian target of rapamycin complex 1 (mTORC1) activation. Biallelic mutation in the LARS gene causes infantile liver failure syndrome type 1 (ILFS1), which is characterized by acute liver failure, anaemia, and neurological disorders, including microcephaly and seizures. However, the molecular mechanism underlying ILFS1 under LARS deficiency has been elusive. Here, we generated Lars deficient (larsb−/−) zebrafish that showed progressive liver failure and anaemia, resulting in early lethality within 12 days post fertilization. The atg5-morpholino knockdown and bafilomycin treatment partially improved the size of the liver and survival rate in larsb−/− zebrafish. These findings indicate the involvement of autophagy in the pathogenesis of larsb−/− zebrafish. Indeed, excessive autophagy activation was observed in larsb−/− zebrafish. Therefore, our data clarify a mechanistic link between LARS and autophagy in vivo. Furthermore, autophagy regulation by LARS could lead to development of new therapeutics for IFLS1.

19 January 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MIMayo Ikeuchi
Mayo Ikeuchi
MIMasanori Inoue
Masanori Inoue
HMHiroaki Miyahara
Hiroaki Miyahara
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
SMShuya Miyazaki
Shuya Miyazaki
THToshikatsu Hanada
Toshikatsu Hanada